Director HTA & Decision Science

At Johnson & Johnsonwe believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented treated and curedwhere treatments are smarter and less invasive andsolutions are our expertise in Innovative Medicine and MedTech we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for more at

As guided by Our Credo Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson we respect the diversity and dignity of our employees and recognize their merit.

Job Function:

Job Sub Function:

Job Category:

All Job Posting Locations:

Job Description:

About Innovative Medicine

Our expertise in Innovative Medicine is informed and inspired by patients whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments finding cures and pioneering the path from lab to life while championing patients every step of the way.

Learn more at & Johnson Innovative Medicine (JJIM) is currently recruiting for a Director Health Technology Assessment & Decision Science (HTA & DS) within the Global Commercial Strategy Organization (GCSO) to be located in Raritan NJ or Beerse Belgium.

The Director Health Technology Assessment & Decision Science (HTA & DS) plays a critical role in informing and shaping internal decision making on our clinical development programs complementary evidence generation and market access strategies across the J&J Innovative Medicine portfolio supporting timely global market access reimbursement and coverage.

The role sits within the Global Commercial Strategy Organizations Market Access Center of Excellence and partners closely with Therapy Area and Regional Market Access R&D Regulatory and other crossfunctional teams worldwide.

Key Responsibilities

• Inform and support internal decision making at internal stage gate governance meetings and functional advisory meetings by

  • translating HTA agency payer and health system insights and benchmarks for key markets ( Japan EU G4 UK) into actionable decisionscience inputs for development programs and access & evidence generation strategies. Leverage generative AI to enable and enhance internal decision making.

  • leading supporting and delivering early HTA agency advice activities including individual agency and multi-agency procedures (e.g. EU Joint Scientific Consultations) across the portfolio in collaboration with product teams.

• EU Joint Clinical Assessments strategy and submission support

  • Represent HTA & DS in EU Joint Clinical Assessment (EU JCA) dossier teams shaping and contributing to delivering PICO strategy and informing dossier development strategy. Ensure cross-program consistency and sharing of key lessons learned.

• Clinical Trial Design/ Protocol Reviews

  • Provide Market Access technical and scientific review at Protocol Review Committee to ensure patient and payerrelevant study designs.

• Capability development

  • Contribute to and deliver HTA capability development internal briefings external positioning documents and external thought leadership.

  • Serve as an HTA & DS expert for product teams providing strategic guidance on HTA agency/ payer requirements and drive organizational learning.

Qualifications and Experience

• Advanced degree (MSc PhD PharmD MD or equivalent) in a relevant discipline (eg. Epidemiology Biostatistics (health) Economics HTA Medicine Public Health).

• At least 7 years of experience in HTA market access evidence generation or related fields in a pharmaceutical organization and/or external agency.

• Strong R&D acumen

• Experience working across multiple therapeutic areas (ideally including one or more of Oncology Immunology Neuroscience Cardiopulmonary) and phase 2 3 development and launch phases.

• Strong understanding of international health care HTA payer and regulatory environments with one or more of Europe the US and Japan preferred.

Capabilities and Leadership Attributes

• Global mindset with proven ability to lead influence and collaborate across diverse global crossfunctional teams.

• Strong strategy development capabilities with the ability to understand synthesize and translate complex evidence into scenario planning and actionable directions.

• Advanced analytical and critical thinking skills.

• Intellectual curiosity and creativity to challenge existing approaches and develop innovative solutions.

• Clear confident communicator (verbal and written).

• Ability to plan prioritize and deliver work effectively in a highly matrixed environment with competing demands.

• Demonstrated commitment to continuous learning and capability development.

Required Skills:

Preferred Skills:

The anticipated base pay range for this position is :

Additional Description for Pay Transparency:

Director